Monitor the company's clinical trial progress and future financing needs, as the current funding is expected to last only through the second half of 2027.
Price Chart
Executive Summary
Spruce Biosciences is raising $59.9 million through a public offering of 1.15 million shares and pre-funded warrants for 50,000 shares, using the proceeds to advance clinical development and pre-commercial activities for its lead product candidate. This is a dilutive capital raise from a company with a history of operating losses.
Key Facts
- Spruce Biosciences is raising $59.9 million through a public offering of 1.15 million shares at $50.00 per share
- The offering includes pre-funded warrants for 50,000 shares with an exercise price of $0.01 per share
- Net proceeds after expenses are estimated at $55.9 million, with potential to reach $64.4 million if underwriters' option is fully exercised
- Proceeds will be used for pre-commercial activities, planned clinical trials, and general corporate purposes
- The company has a history of operating losses and will need additional financing beyond this offering
Financial Impact
$55.9 million in net proceeds, with $59.9 million gross proceeds
Risk Factors
- Dilution to existing shareholders from the new share issuance
- Continued need for additional financing beyond this offering
- Lack of established market for pre-funded warrants
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001193125-26-167256 |
| Document: 0001193125-26-167256-index-headers.html | 0001193125-26-167256 |
| Document: 0001193125-26-167256-index.html | 0001193125-26-167256 |
| Document: 0001193125-26-167256.txt | 0001193125-26-167256 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 12, 2026 10w ago | 8-K | $47.07 $54.35 | ▲ +15.47% | ▲ +17.36% | $43.99 (−6.54%) |
May 13, 2026 23w ago | 8-K | $57.55 $49.11 | ▼ −14.67% | ▼ −14.06% | $43.99 (−23.56%) |
Apr 21, 2026 26w ago | 424B5 | $52.36 $48.25 | ▼ −7.85% | ▼ −11.01% | $43.99 (−15.99%) |
Apr 20, 2026 27w ago | 424B5 | $51.69 $51.41 | ▼ −0.54% | ▼ −5.46% | $43.99 (−14.90%) |
Mar 9, 2026 33w ago | 8-K | $62.11 $62.15 | ▲ +0.06% | ▲ +2.87% | $43.99 (−29.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers